The Companion Animal Parasite Council’s 2026 forecast projects continued expansion of Lyme disease, heartworm, ehrlichiosis, and anaplasmosis, reinforcing the need for year-round prevention and surveillance.
The FDA has approved an expanded label for BRAVECTO QUANTUM, adding 12-month protection against Asian longhorned and Gulf Coast ticks in dogs.
Veterinarians across the U.S. are seeing early parasite activity as temperatures rise, reinforcing the need for year-round prevention in pets.
The FDA has approved expanded labels for Elanco’s Credelio™ and Credelio Quattro™, adding prevention of Lyme disease and protection against the rapidly spreading longhorned tick—now found in 22 U.S. states.
The FDA has granted an Emergency Use Authorization for Elanco’s Credelio™ (lotilaner) to treat New World screwworm infestations in dogs—marking the first authorization of its kind as the parasite nears the U.S. border.